Comparing MiLEP and standard EEP for treating prostate enlargement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the safety and efficacy of MiLEP, a modified endoscopic technique using smaller instruments, against the standard endoscopic enucleation of the prostate (EEP) for patients with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). The study will utilize a thulium fiber laser for both procedures and assess outcomes such as rates of stress urinary incontinence and urethral strictures. Participants will be selected based on specific criteria related to their urinary symptoms and prostate health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

LUTS presence, proven by:

1. IPSS questionnaire (Score \>20);
2. OR uroflowmetry result (Qmax \<10 ml/s);

Exclusion Criteria:

* Prostate volume \> 120 cc
* Prostate cancer on pathology;
* Urethral strictures;
* Bladder calculi;
* Prior prostate surgery;
* Neurogenic bladder dysfunction.

Where it's running

• Institute for Urology and Reproductive Health, Sechenov University
  Moscow, Russia Recruiting

Study contacts

• Study coordinator: Vladislav Petov, Associate Professor, urologist
• Email: pettow@mail.ru
• Phone: +7 925 351 75 49

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MISTER: Steam Therapy for BPH in real-world practice

  This study tests Rezūm steam therapy for men with moderate-to-severe BPH and LUTS to see how well it works in real-world clinics.

  Recruiting Sechenov University · Moscow · NCT07723378

• Transurethral Thermodilatation vs Prostatic Urethral Lift for BPH in men 50–80

  This study tests whether Prolieve can match UroLift in relieving BPH symptoms in men 50–80 who haven’t had enough relief from medicines.

  Recruiting The University of Hong Kong · Hong Kong · NCT07759752

• Oxiblume:CoQ10 (Ralivia) Therapy for Benign Prostatic Hyperplasia: a comparison to placebo

  This study tests whether Oxiblume:CoQ10 (Ralivia) can improve symptoms for men with BPH compared to a placebo.

  Recruiting G.Gennimatas General Hospital · Thessaloniki · NCT07638865

• Early versus delayed catheter removal in men with sudden urinary retention

  This trial will test whether removing the catheter after 3 days or after 14 days helps men with sudden urinary retention (usually from an enlarged prostate) urinate without the catheter.

  Recruiting at 7 sites Isala · Harderwijk, Gelderland and 10 other locations · NCT07283484

• Evaluating Tryptophan for Treating BPH Symptoms

  This study is testing whether Tryptophan can help men with BPH symptoms feel better without the sexual side effects that come with usual treatments.

  Recruiting Phase 2 Clinical Academic Center (2CA-Braga) · Braga · NCT05401032

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.